Back

Defining the limits of transcatheter valve repair: a prospective comparison of multivalvular interventions in the atrial fibrillation triad

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Valve interventions for mitral regurgitation Mitral Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Alica Cesnakova Konecna

Hospital Podlesi, Trinec (Czechia)

5 More presentations in this session

Presentation thumbnail
Predictors of early death after transcatheter edge-to-edge mitral valve repair: results from the MAVERICK registry
Doctor A. SOUQUET (Paris, FR)
Abstract
Presentation thumbnail
Sex-specific differences and outcomes of transcatheter mitral valve replacement in women
Doctor I. Von Der Heide (Hamburg, DE)
Abstract
Presentation thumbnail
6 months follow-up after mitral transcatheter edge-to-edge repair: clinical and procedural determinates that may affect residual mitral regurgitation
Mr P. Stoeckl (Vienna, AT)
Abstract
Presentation thumbnail
Futility and event-free survival predictors of mitral valve edge-to-edge repair in patients with advanced heart failure evaluated for heart transplantation
Mr J. Martin Diaz (Cordoba, ES)
Abstract
Presentation thumbnail
Iatrogenic ASD gradient as a marker of residual mitral regurgitation severity after M-TEER procedure
Doctor A. Kalompatsou (Athens, GR)
Abstract

Access the full session

Session thumbnail
Valve interventions for mitral regurgitation

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical and haemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation
27 August 2021
thumbnail
Congress Session
Epicardial/endocardial hybrid treatments: combining strengths, restoring rhythm
30 March 2025
thumbnail
Congress Presentation
The impact of severe tricuspid regurgitation on quality of life among patients with atrial fibrillation
13 December 2024
thumbnail
Congress Session
Managing patients with multivalvular disease: expert insights
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources